We are live on ! Find out more
AWM

Aspire Wealth Management Portfolio holdings

AUM $186M
1-Year Est. Return 28.97%
This Fund
S&P 500
This Quarter Est. Return
+1.18%
1 Year Est. Return
+28.97%
3 Year Est. Return
+26.02%
5 Year Est. Return
10 Year Est. Return
AUM
$175M
AUM Growth
+$9.1M
Cap. Flow
+$7.74M
Cap. Flow %
4.43%
Top 10 Hldgs %
48.41%
Holding
191
New
5
Increased
62
Reduced
60
Closed
11
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYG icon
151
iShares US Financial Services ETF
IYG
$2.16B
$16.5K 0.01%
253
-1
-0.4% -$65
IWR icon
152
iShares Russell Mid-Cap ETF
IWR
$56.1B
$16.1K 0.01%
198
SIZE icon
153
iShares MSCI USA Size Factor ETF
SIZE
$430M
$12.5K 0.01%
91
-7
-7% -$963
IJR icon
154
iShares Core S&P Small-Cap ETF
IJR
$110B
$10.1K 0.01%
95
-12
-11% -$1.28K
IXC icon
155
iShares Global Energy ETF
IXC
$2.77B
$9.84K 0.01%
237
-2,974
-93% -$127K
SPIB icon
156
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$9.71K 0.01%
298
-450
-60% -$14.6K
RSP icon
157
Invesco S&P 500 Equal Weight ETF
RSP
$97.2B
$9.04K 0.01%
55
VNQ icon
158
Vanguard Real Estate ETF
VNQ
$39.4B
$8.8K 0.01%
105
PDP icon
159
Invesco Dorsey Wright Momentum ETF
PDP
$1.45B
$8.32K ﹤0.01%
85
OEF icon
160
iShares S&P 100 ETF
OEF
$19.9B
$7.14K ﹤0.01%
27
-10
-27% -$2.5K
DVY icon
161
iShares Select Dividend ETF
DVY
$23.6B
$5.81K ﹤0.01%
48
IHF icon
162
iShares US Healthcare Providers ETF
IHF
$1.21B
$5.79K ﹤0.01%
110
PBE icon
163
Invesco Biotechnology & Genome ETF
PBE
$286M
$5.77K ﹤0.01%
89
XSOE icon
164
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.01B
$5.07K ﹤0.01%
165
-102
-38% -$3.06K
ITB icon
165
iShares US Home Construction ETF
ITB
$2.29B
$3.84K ﹤0.01%
38
EFIV icon
166
State Street SPDR S&P 500 ESG ETF
EFIV
$989M
$2.44K ﹤0.01%
+46
New +$2.34K
EFA icon
167
iShares MSCI EAFE ETF
EFA
$78.5B
$1.34K ﹤0.01%
17
IGSB icon
168
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$1.29K ﹤0.01%
25
-216
-90% -$11K
MUB icon
169
iShares National Muni Bond ETF
MUB
$45.2B
$569 ﹤0.01%
5
-93
-95% -$9.9K
IBB icon
170
iShares Biotechnology ETF
IBB
$9.52B
$555 ﹤0.01%
4
IWC icon
171
iShares Micro-Cap ETF
IWC
$1.45B
$480 ﹤0.01%
4
EEM icon
172
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$467 ﹤0.01%
11
IHI icon
173
iShares US Medical Devices ETF
IHI
$3.14B
$412 ﹤0.01%
7
-187
-96% -$10.5K
MOO icon
174
VanEck Agribusiness ETF
MOO
$994M
$302 ﹤0.01%
4
TFLO icon
175
iShares Treasury Floating Rate Bond ETF
TFLO
$6.54B
$253 ﹤0.01%
5
-71
-93% -$3.59K

Similar funds

Aspire Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, Aspire Wealth Management held 191 positions worth $175M, up 5.5% from $166M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Aspire Wealth Management deployed $7.74M of net new capital in Q2 2024, opening 5 new positions and adding to 62 existing holdings. Its largest new stake was Columbia Research Enhanced Core ETF: 17,002 shares worth $549K.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Schwab US Dividend Equity ETF, an estimated $2.42M trimmed.

  • Aspire Wealth Management's largest Q2 2024 buy was Columbia Research Enhanced Core ETF: 17,002 shares worth $549K.
  • Aspire Wealth Management added most to NYLI FTSE International Equity Currency Neutral ETF in Q2 2024, an estimated $2.7M increase.
  • Aspire Wealth Management's biggest Q2 2024 reduction was Schwab US Dividend Equity ETF, cutting an estimated $2.42M.
  • Aspire Wealth Management fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2024, selling an estimated $236K.
  • Aspire Wealth Management's ten largest holdings make up 48% of its $175M portfolio in Q2 2024.
  • Aspire Wealth Management opened 5 new positions and closed 11 in Q2 2024.
  • Aspire Wealth Management's portfolio value rose 5.5% quarter-over-quarter to $175M.

Based on Aspire Wealth Management's 13F filing for Q2 2024, filed 12 Aug 2024.